Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Allen

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
Pediatrics|April 8, 2026
Enteric Viral Pathogens in Infants in the United States: 2017-2020Jennifer L Cannon, Julia M Baker, Claire P Mattison, et al.
Journal of the Pediatric Infectious Diseases Society|August 31, 2024
Evaluation of a Modified Vesikari Severity Score as a Research Tool for Assessing Pediatric Acute GastroenteritisMary E Wikswo, Geoffrey A Weinberg, Peter G Szilagyi, et al.
JAMA Pediatrics|January 6, 2025
Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical TrialRachel G Greenberg, Wes Rountree, Mary Allen Staat, et al.
The Lancet. Infectious Diseases|May 17, 2011
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda E Gray, Mary Allen, Zoe Moodie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Vaccine|November 11, 2008
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trialPaul Spearman, Spyros Kalams, Marnie Elizaga, et al.
AIDS and Behavior|March 17, 2023
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South AfricaMookho Malahleha, Fatima Laher, Athmanundh Dilraj, et al.
Open Forum Infectious Diseases|January 29, 2021
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 VaccineesKarina Oganezova, Elvin J Fontana-Martinez, Jon A Gothing, et al.
The Journal of Infectious Diseases|March 7, 2024
HIV Diagnostics and Vaccines: It Takes Two to TangoWill Colón, Valérie Oriol-Mathieu, John Hural, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2016
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year GapGlenda E Gray, Kenneth H Mayer, Marnie L Elizaga, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
Pediatrics|April 8, 2026
Enteric Viral Pathogens in Infants in the United States: 2017-2020Jennifer L Cannon, Julia M Baker, Claire P Mattison, et al.
Journal of the Pediatric Infectious Diseases Society|August 31, 2024
Evaluation of a Modified Vesikari Severity Score as a Research Tool for Assessing Pediatric Acute GastroenteritisMary E Wikswo, Geoffrey A Weinberg, Peter G Szilagyi, et al.
JAMA Pediatrics|January 6, 2025
Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical TrialRachel G Greenberg, Wes Rountree, Mary Allen Staat, et al.
The Lancet. Infectious Diseases|May 17, 2011
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda E Gray, Mary Allen, Zoe Moodie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120Farley Cleghorn, Jean W Pape, Mauro Schechter, et al.
Vaccine|November 11, 2008
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trialPaul Spearman, Spyros Kalams, Marnie Elizaga, et al.
AIDS and Behavior|March 17, 2023
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South AfricaMookho Malahleha, Fatima Laher, Athmanundh Dilraj, et al.
Open Forum Infectious Diseases|January 29, 2021
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 VaccineesKarina Oganezova, Elvin J Fontana-Martinez, Jon A Gothing, et al.
The Journal of Infectious Diseases|March 7, 2024
HIV Diagnostics and Vaccines: It Takes Two to TangoWill Colón, Valérie Oriol-Mathieu, John Hural, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2016
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year GapGlenda E Gray, Kenneth H Mayer, Marnie L Elizaga, et al.
Pageof 21